陈一沧;刘伟;张超;孟增东;

• 1:昆明医学院附属昆华医院骨科
• 2:云南省第一人民医院骨科

摘要(Abstract)：

<正>糖尿病(diabetes mellitus,DM)是一组常见的以血浆葡萄糖水平增高为特征的代谢内分泌疾病,无论是1型还是2型都可存在不同程度的骨量改变,影响骨的合成代谢。随着人口老龄化,人们生活水平的提高以及糖尿病诊断

关键词(KeyWords)： 糖尿病;人工关节假体;骨整合;骨质疏松;稳定性

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 陈一沧;刘伟;张超;孟增东;

Email:

DOI:

参考文献(References)：

• [1]李宝新,黄怡,李玉坤.糖尿病与骨代谢相关研究进展[J].医学综述,2008,18:2837-2839.
• [2]Kayal RA,Tsatsas D,Bauer MA,et al.Diminished bone formation dur-ing diabetic fracture healing is related to the premature resorption ofcartilage associated with increased osteoclast activity[J].J Bone MinerRes,2007,4:560-568.
• [3]Heap J,Murray MA,Miller SC,et al.Alterations in bone characteris-tics associated with glycemic control in adolescents with typeⅠdiabe-tes mellitus[J].J Pediatr,2004,1:56-62.
• [4]Yamamoto M,Yamaguchi T,Yamauchi M,et al.Serum pentosidinelevels are positively associated with the presence of vertebral flracturesin postmenopausal women with type 2 diabetes[J].J Clin EndocrinolMetab,2008,3:1013-1019.
• [5]Fujii H,Hamada Y,Fukagawa M.Bone formation in spontaneously dia-betie Torii-newly established model of non-obese type 2 diabetesrats[J].Bone,2008,2:372-379.
• [6]Botolin S,Faugere MC,Malluehe H,et al.Increased bone adiposityand peroxisomal proliferator-activated receptor-gamma2 expressionin type I diabetic mice[J].Endocrinology,2005,8:3622-3631.
• [7]Ahmed N,Thornalley PJ.Advanced glycation endproducts:what istheir relevance to diabetic complications[J].Diabetes Obes Metab,2007,3:233-245.
• [8]Hernandez CJ,Tang SY,Baumbach BM,et al.Tabecular microfractureand the influence of pyridinium and non-enzymatic glycation media-ted collagen cross-links[J].Bone,2005,6:825-832.
• [9]Viguet-Carrin S,Roux JP,Arlot ME,et al.Contribution of the ad-vanced glycation end product pentosidine and of maturation of type Icollagen to compressive biomechanical properties of human lumbar ver-tebrae[J].Bone,2006,5:1073-1079.
• [10]Alikhani M,Alikhani Z,Boyd C,et al.Advanced glycation end prod-ucts stimulate osteoblast apoptosis via the MAP kinase and cytosolicapoptotic pathways[J].Bone,2007,2:345-353.
• [11]Fatokun AA,Stone TW,Smith RA.Hydrogen peroxide-induced oxi-dative stress in MC3T3-El cells:the effects of glutamate and protec-tion by purines[J].Bone,2006,3:542-551.
• [12]Hamada Y,Kitazawa S,Kitazawa R,et al.Histomorphometric analysisof diabetic osteopenia in streptozotocin-induced-diabetic mice:apossible role of oxidative stress[J].Bone,2007,5:1408-1414.
• [13]Fang Y,Wang ZY,Mao Y,et al.Effects of insulin-like growth factor Ion the development of osteoblasts in hyperglycemia[J].Diabetes ResClin Pract,2006,1:95-97.
• [14]Fei Y,Zhang M,Li M,et al.Element analysis in femur of diabetic os-teoporosis model by SRXRF microprobe[J].Micron,2007,6:637-642.
• [15]Rakel A,Sheehy O,Rahme E,et al.Osteoporosis among patients withtype 1 and type 2 diabetes[J].Diabetes Metab,2008,3:193-205.
• [16]刘海叶,刘泽,邓伟民.糖尿病引发骨质疏松症的机制及防治[J].中国骨质疏松杂志,2008,7:529-531.
• [17]Learmonth ID,Young C,Rorabeck C.The operation of the century:to-tal hip replacement[J].Lancet,2007,9597:1508-1519.
• [18]Trieb K,Schmid M,Stulnig T,et al.Long-term outcome of total kneereplacement in patients with rheumatoid arthritis[J].Joint BoneSpine,2008,2:163-166.
• [19]Bordini B,Stea S,De Clerico M,et al.Factors affecting aseptic loose-ning of 4750 total hip arthroplasties:multivariate survival analysis[J].BMC Musculoskelet Disord,2007,8:69.
• [20]Holt G,Murnaghan C,Reilly J,et al.The biology of aseptic osteolysis[J].Clin Orthop,2007,460:240-252.
• [21]刘蓉.2型糖尿病患者实施人工关节置换围手术期的风险探讨[J].中国组织工程研究与临床康复,2009,13:2557-2560.
• [22]Shyng YC,Devlin H,Ou KL.Bone formation around immediatelyplaced oral implants in diabetic rats[J].Int J Prosthodont,2006,5:513-514.
• [23]Mellado-Valero A,Ferrer-Garcia JC,Herrera-Ballester A,et al.Effects of diabetes on the osseointegration of dental implants[J].MedOral Patol Oral Cir Bucal,2007,1:38-43.
• [24]Kotsovilis S,Karoussis IK,Fourmousis I.A comprehensive and criticalreview of dental implant placement in diabetic animals and patients[J].Clin Oral Implants Res,2006,5:587-599.
• [25]Kwon PT,Rahman SS,Kim DM,et al.Maintenance of osseointegrationutilizing insulin therapy in a diabetic rat model[J].J Periodontol,2005,4:621-626.
• [26]刘亚非.糖尿病患者行人工关节置换术的相关研究[D].河北医科大学,2008.
• [27]Hasegawa H,Ozawa S,Hashimoto K,et al.Type 2 diabetes impairs im-plant osseointegration capacity in rats[J].Int J Oral Maxillofac Im-plants,2008,2:237-246.
• [28]林纯毅.胰岛素干预糖尿病骨质疏松症的临床研究[J].海峡药学,2007,11:76.
• [29]林华,朱秀芬,陈新,等.胰岛素对糖尿病鼠骨量和骨生物力学的影响[J].中国骨质疏松杂志,2007,12:872-875.
• [30]Thrailkill KM,Lumpkin CK Jr,Bunn RC,et al.Is insulin an anabolicagent in bone?Dissecting the diabetic bone for clues[J].Am J Physi-ol Endocrinol Metab,2005,5:735-745.
• [31]de Liefde II,Van de Klifi M,de Laet CE,et al.Bone mineral densityand fracture risk in type.2 diabetes mellitus:the Rotterdam Study[J].Osteoporos Int,2005,16:1713-1720.
• [32]Gandhi A,Beam HA,O’Connor JP,et al.The effects of local insulindelivery on diabetic fracture healing[J].Bone,2005,4:482-490.
• [33]Follak N,Kl ting I,Wolf E,et al.Improving metabolic control reversesthe histomorphometric and biomechanical abnormalities of an experi-mentally induced bone defect in spontaneously diabetic rats[J].CalcifTissue Int,2004,6:551-560.